Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 8,353 |
|
|||||
| News | - | ||||||
| Day High | 2.99 | Low High |
|||||
| Day Low | 2.7001 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| XORTX Therapeutics Inc | XRTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.06 | -2.00% | 2.94 | 17:00:02 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.99 | 2.7001 | 2.99 | 2.94 | 3.00 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 108 | 8,353 | $ 2.87 | $ 23,942 | - | 1.98 - 7.524 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:38:24 | 50 | $ 2.86 | USD |
XORTX Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.9M | 2.00M | - | 0 | -2.16M | -1.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
XORTX Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XRTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.10 | 3.30 | 2.7001 | 3.04 | 15,948 | -0.16 | -5.16% |
| 1 Month | 3.85 | 3.99 | 2.7001 | 3.46 | 19,853 | -0.91 | -23.64% |
| 3 Months | 2.46 | 7.00 | 2.20 | 4.39 | 52,275 | 0.48 | 19.51% |
| 6 Months | 4.1049 | 7.00 | 1.98 | 3.48 | 131,709 | -1.16 | -28.38% |
| 1 Year | 6.3909 | 7.524 | 1.98 | 5.27 | 485,748 | -3.45 | -54.00% |
| 3 Years | 31.32 | 53.01 | 1.98 | 13.82 | 462,499 | -28.38 | -90.61% |
| 5 Years | 31.32 | 53.01 | 1.98 | 13.82 | 462,499 | -28.38 | -90.61% |
XORTX Therapeutics Description
| XORTX Therapeutics Inc is a clinical-stage biotechnology company. The company focused on developing drug therapies for orphan diseases like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes. |
